Biodesix, Inc. (BDSX)

USD 1.34

(-3.6%)

Operating Expenses Summary of Biodesix, Inc.

  • Biodesix, Inc.'s latest annual operating expenses in 2023 was 77.41 Million USD , down -0.07% from previous year.
  • Biodesix, Inc.'s latest quarterly operating expenses in 2024 Q2 was 22.21 Million USD , down -1.67% from previous quarter.
  • Biodesix, Inc. reported a annual operating expenses of 74.56 Million USD in annual operating expenses 2022, up 17.78% from previous year.
  • Biodesix, Inc. reported a annual operating expenses of 63.3 Million USD in annual operating expenses 2021, up 38.6% from previous year.
  • Biodesix, Inc. reported a quarterly operating expenses of 22.59 Million USD for 2024 Q1, up 24.56% from previous quarter.
  • Biodesix, Inc. reported a quarterly operating expenses of 26.74 Million USD for 2024 Q3, up 1.55% from previous quarter.

Annual Operating Expenses Chart of Biodesix, Inc. (2023 - 2018)

Historical Annual Operating Expenses of Biodesix, Inc. (2023 - 2018)

Year Operating Expenses Operating Expenses Growth
2023 77.41 Million USD -0.07%
2022 74.56 Million USD 17.78%
2021 63.3 Million USD 38.6%
2020 45.67 Million USD 11.12%
2019 41.1 Million USD 20.59%
2018 34.08 Million USD 0.0%

Peer Operating Expenses Comparison of Biodesix, Inc.

Name Operating Expenses Operating Expenses Difference
Bionano Genomics, Inc. 148.99 Million USD 48.038%
Prenetics Global Limited 60.73 Million USD -27.467%
Star Equity Holdings, Inc. 16.27 Million USD -375.78%
CareDx, Inc 277.76 Million USD 72.128%
Exact Sciences Corporation 2.06 Billion USD 96.243%
Exagen Inc. 52.29 Million USD -48.048%
Inotiv, Inc. 246.9 Million USD 68.644%
Guardant Health, Inc. 901.62 Million USD 91.413%
BioNexus Gene Lab Corp. 3.92 Million USD -1873.421%
Precipio, Inc. 13.63 Million USD -467.671%
iSpecimen Inc. 16.27 Million USD -375.627%
Natera, Inc. 938.98 Million USD 91.755%
Aspira Women's Health Inc. 24.11 Million USD -221.054%
Standard BioTools Inc. 113.48 Million USD 31.783%
23andMe Holding Co. 420.73 Million USD 81.599%
Castle Biosciences, Inc. 242.78 Million USD 68.112%
Personalis, Inc. 128.14 Million USD 39.584%
Aclaris Therapeutics, Inc. 110.52 Million USD 29.953%
Applied DNA Sciences, Inc. 16.48 Million USD -369.584%
OpGen, Inc. 30.65 Million USD -152.525%
T2 Biosystems, Inc. 41.49 Million USD -86.579%
Myriad Genetics, Inc. 600.1 Million USD 87.099%
ICON Public Limited Company 755.64 Million USD 89.755%
NeoGenomics, Inc. 341.25 Million USD 77.313%
Star Equity Holdings, Inc. 16.27 Million USD -375.78%
IDEXX Laboratories, Inc. 1.09 Billion USD 92.916%
RadNet, Inc. 268.87 Million USD 71.207%
MDxHealth SA 71.25 Million USD -8.649%
Psychemedics Corporation 11.33 Million USD -583.069%
Illumina, Inc. 3.81 Billion USD 97.97%
Check-Cap Ltd. 19.28 Million USD -301.405%
Twist Bioscience Corporation 354.18 Million USD 78.141%
DarioHealth Corp. 62.17 Million USD -24.522%
Fulgent Genetics, Inc. 171.9 Million USD 54.964%
Sera Prognostics, Inc. 39.91 Million USD -93.95%
ENDRA Life Sciences Inc. 10.52 Million USD -635.871%
OPKO Health, Inc. 574.68 Million USD 86.528%
Medpace Holdings, Inc. 187.68 Million USD 58.749%
Neogen Corporation 405.23 Million USD 80.895%
Intelligent Bio Solutions Inc. 11.7 Million USD -561.204%
Prenetics Global Limited 60.73 Million USD -27.467%
Mainz Biomed B.V. 27.15 Million USD -185.107%
bioAffinity Technologies, Inc. 8.76 Million USD -783.29%
Trinity Biotech plc 46.49 Million USD -66.51%
Neuronetics, Inc. 82.25 Million USD 5.884%
Sotera Health Company 300.46 Million USD 74.234%
bioAffinity Technologies, Inc. 8.76 Million USD -783.29%